|Brand name(s), other common name(s)||Kepivance®|
|Drug type||Growth factor|
|How the drug is given||Intravenously (IV)|
Indications and Usage
Palifermin is FDA approved to help prevent or lessen severe oral mucositis (inflammation of the mucous membrane of the mouth) in patients receiving certain types of blood cancer therapy.
Side effects needing medical attention
Check with your doctor immediately if you develop a rash.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.